Subscribe To
Canada q4 current account -10.64b vs -10.90b expected
- Prior -11.1b (revised to -8.418B)
This isn't a market mover.
This article was w...February 27, 2023, 1:30 pm
Amc entertainment revenue predicted to miss expectations
AMC Entertainment Holdings (NYSE:AMC) will tomorrow report revenues shy of expectations, that's according to analysts at stockbroker Wedbush, which ha...
February 27, 2023, 9:09 am
Celldex therapeutics presents positive data from barzolvolimab phase 1b study in chronic spontaneous urticaria at aaaai 2023
– Rapid, profound and durable responses across multiple dosing groups with favorable safety profile observed—positioning barzolimab as a potential...
February 26, 2023, 2:00 pm
Arch resources delivers on capital returns
Arch Resources had a tremendous 2022, generating over $1b in cash despite numerous headwinds. Going int...
February 24, 2023, 10:23 am
Astrazeneca signs deal to produce new gastric cancer drug
AstraZeneca PLC (LSE:AZN), Britain's largest pharmaceutical company, has agreed a licensing deal with KYM Biosciences Inc for a potential drug treatm...
February 23, 2023, 6:29 am
Bill gates buys nearly $1b heineken stake — despite not being a ‘big beer drinker'
Gates purchased 10.8 million shares, worth 883 million euros ($939.87 million) at current market prices...
February 22, 2023, 11:20 am
With 1b users as goal, coinbase ceo turns 2023 focus to regulation
Coinbase is focused on controlling what can be controlled and contingency planning for what can't. This, as a year full of idiosyncratic events, batt...
February 21, 2023, 9:38 pm
Glencore underpinned by effective 18% yield, according to barclays
Glencore is still in favour with analysts at Barclays, which despite weakening coal income reckon payouts this year amount to an effective 18% yield t...
February 20, 2023, 10:17 am
Snap announces 750m monthly active users, could hit 1b in next 2-3 years
CNBC's Julia Boorstin reports on Snap CEO Evan Spiegel's remarks about the company's growth today. With CNBC's Scott Wapner and the 'Halftime Report' ...
February 16, 2023, 1:34 pm
Bp plc to invest us$1bn in american ev chargers as part of hertz tie-up
BP PLC (LSE:BP.) has announced its intention to invest some US$1bn to expand its network of electric ve...
February 15, 2023, 4:17 pm
Glencore hands $7.1b to shareholders after record profit
Glencore had one of its greatest years on record, cutting debt to $75 million from $6 billion, and returning $7.1 billion to shareholders, as demand s...
February 15, 2023, 3:41 pm
Glencore shares nudge 2% lower as market says 'meh' to us$7.1bn cash return
Proving the old stock market adage that it's better to travel than arrive, shares in Glencore PLC lost 2% of their value in opening salvos – even af...
February 15, 2023, 3:38 am
Barclays plc profits fall, dented by increased litigation charges
Barclays PLC (LSE:BARC) reported a fall in annual pre-tax profits hit by litigation charges relating to the over-issuance of securities. The high stre...
February 15, 2023, 2:49 am
Godaddy says revenue and cash flow growth was strong in q4
GoDaddy (NYSE:GDDY) told investors it has delivered strong revenue and cash flow growth in 2022, despite macroeconomic headwinds. The internet domains...
February 14, 2023, 4:43 pm
Unilever: scene set for new ceo, but are the shares worth a punt?
Unilever PLC (LSE:ULVR)'s new CEO Hein Schumacher has joined the company at an opportune time with €1b...
February 14, 2023, 6:51 am
Coca-cola hbc reports fall in full-year net profits
Coca-Cola HBC, the strategic bottling partner of The Coca-Cola Company (NYSE:KO), reported a fall in full-year net profits despite an uptick in organi...
February 14, 2023, 3:05 am
Pboc sets usd/ cny central rate at 6.8136 (vs. estimate at 6.8138)
People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.CNH is the offshore yuan. USD /CNH has no restrictio...
February 14, 2023, 1:18 am
Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer
HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...
February 13, 2023, 5:00 pm
Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer
HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...
February 13, 2023, 5:00 pm
Aravive to present positive updated data from phase 1b trial of batiraxcept in combination with cabozantinib for treatment of clear cell renal cell carcinoma at the 2023 asco genitourinary (gu) cancer
HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted...
February 13, 2023, 5:00 pm
